131 related articles for article (PubMed ID: 11641056)
1. Nuclear localization of beta-catenin in the hair matrix cells and differentiated keratinocytes.
Tsuji H; Ishida-Yamamoto A; Takahashi H; Iizuka H
J Dermatol Sci; 2001 Nov; 27(3):170-7. PubMed ID: 11641056
[TBL] [Abstract][Full Text] [Related]
2. Beta-catenin expression in benign and malignant pilomatrix neoplasms.
Hassanein AM; Glanz SM
Br J Dermatol; 2004 Mar; 150(3):511-6. PubMed ID: 15030335
[TBL] [Abstract][Full Text] [Related]
3. beta-catenin expression in pilomatrixomas. Relationship with beta-catenin gene mutations and comparison with beta-catenin expression in normal hair follicles.
Moreno-Bueno G; Gamallo C; Pérez-Gallego L; Contreras F; Palacios J
Br J Dermatol; 2001 Oct; 145(4):576-81. PubMed ID: 11703283
[TBL] [Abstract][Full Text] [Related]
4. Expression patterns of hair and epithelial keratins and transcription factors HOXC13, LEF1, and beta-catenin in a malignant pilomatricoma: a histological and immunohistochemical study.
Cribier B; Worret WI; Braun-Falco M; Peltre B; Langbein L; Schweizer J
J Cutan Pathol; 2006 Jan; 33(1):1-9. PubMed ID: 16441405
[TBL] [Abstract][Full Text] [Related]
5. On the regulation of hair keratin expression: lessons from studies in pilomatricomas.
Cribier B; Peltre B; Grosshans E; Langbein L; Schweizer J
J Invest Dermatol; 2004 May; 122(5):1078-83. PubMed ID: 15140206
[TBL] [Abstract][Full Text] [Related]
6. beta-Catenin expression in the transitional cell zone of pilomatricoma.
Park SW; Suh KS; Wang HY; Kim ST; Sung HS
Br J Dermatol; 2001 Oct; 145(4):624-9. PubMed ID: 11703290
[TBL] [Abstract][Full Text] [Related]
7. Dynamic expression and nuclear accumulation of beta-catenin during the development of hair follicle-derived structures.
Ridanpää M; Fodde R; Kielman M
Mech Dev; 2001 Dec; 109(2):173-81. PubMed ID: 11731231
[TBL] [Abstract][Full Text] [Related]
8. TGF-β1-dependent induction and nuclear translocation of FHL2 promotes keratin expression in pilomatricoma.
Friedrichs J; Fink D; Mauch C; Kindler D; Hartmann W; Schüle R; Buettner R; Friedrichs N
Virchows Arch; 2015 Feb; 466(2):199-208. PubMed ID: 25477051
[TBL] [Abstract][Full Text] [Related]
9. beta-Catenin mutation and its nuclear localization are confirmed to be frequent causes of Wnt signaling pathway activation in pilomatricomas.
Xia J; Urabe K; Moroi Y; Koga T; Duan H; Li Y; Furue M
J Dermatol Sci; 2006 Jan; 41(1):67-75. PubMed ID: 16378715
[TBL] [Abstract][Full Text] [Related]
10. beta-Catenin gene mutation in human hair follicle-related tumors.
Kajino Y; Yamaguchi A; Hashimoto N; Matsuura A; Sato N; Kikuchi K
Pathol Int; 2001 Jul; 51(7):543-8. PubMed ID: 11472567
[TBL] [Abstract][Full Text] [Related]
11. Expression pattern of human hair keratin basic 1 (hHb1) in hair follicle and pilomatricoma.
Régnier CH; Asch PH; Grosshans E; Rio MC
Exp Dermatol; 1997 Apr; 6(2):87-90. PubMed ID: 9209890
[TBL] [Abstract][Full Text] [Related]
12. Immunohistochemical Localization of Phosphorylated and Unphosphorylated Form of β-catenin With Regard to Shadow Cell and Squamous Differentiation in Cutaneous Pilomatricoma.
Nakamura T; Fujiwara M
Am J Dermatopathol; 2020 Nov; 42(11):835-841. PubMed ID: 32310857
[TBL] [Abstract][Full Text] [Related]
13. Pilomatricoma can differentiate not only towards hair matrix and hair cortex, but also follicular infundibulum, outer root sheath and hair bulge.
Kurokawa I; Yamanaka K; Senba Y; Sugisaki H; Tsubura A; Kimura T; Mizutani H
Exp Dermatol; 2009 Aug; 18(8):734-7. PubMed ID: 19469893
[TBL] [Abstract][Full Text] [Related]
14. A common human skin tumour is caused by activating mutations in beta-catenin.
Chan EF; Gat U; McNiff JM; Fuchs E
Nat Genet; 1999 Apr; 21(4):410-3. PubMed ID: 10192393
[TBL] [Abstract][Full Text] [Related]
15. De Novo hair follicle morphogenesis and hair tumors in mice expressing a truncated beta-catenin in skin.
Gat U; DasGupta R; Degenstein L; Fuchs E
Cell; 1998 Nov; 95(5):605-14. PubMed ID: 9845363
[TBL] [Abstract][Full Text] [Related]
16. Low frequency of beta-catenin gene mutations in pilomatricoma.
Ha SJ; Kim JS; Seo EJ; Lee KH; Lee HJ; Kim JW
Acta Derm Venereol; 2002; 82(6):428-31. PubMed ID: 12575848
[TBL] [Abstract][Full Text] [Related]
17. beta-Catenin is expressed aberrantly in tumors expressing shadow cells. Pilomatricoma, craniopharyngioma, and calcifying odontogenic cyst.
Hassanein AM; Glanz SM; Kessler HP; Eskin TA; Liu C
Am J Clin Pathol; 2003 Nov; 120(5):732-6. PubMed ID: 14608900
[TBL] [Abstract][Full Text] [Related]
18. Pilomatrix carcinomas contain mutations in CTNNB1, the gene encoding beta-catenin.
Lazar AJ; Calonje E; Grayson W; Dei Tos AP; Mihm MC; Redston M; McKee PH
J Cutan Pathol; 2005 Feb; 32(2):148-57. PubMed ID: 15606674
[TBL] [Abstract][Full Text] [Related]
19. Aberrantly differentiated cells in benign pilomatrixoma reflect the normal hair follicle: immunohistochemical analysis of Ca-binding S100A2, S100A3 and S100A6 proteins.
Kizawa K; Toyoda M; Ito M; Morohashi M
Br J Dermatol; 2005 Feb; 152(2):314-20. PubMed ID: 15727645
[TBL] [Abstract][Full Text] [Related]
20. beta-Catenin controls hair follicle morphogenesis and stem cell differentiation in the skin.
Huelsken J; Vogel R; Erdmann B; Cotsarelis G; Birchmeier W
Cell; 2001 May; 105(4):533-45. PubMed ID: 11371349
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
